StrokeBelt Network to improve stroke care in the Southeast
StrokeBelt StrokeNet
This program links hospitals in the Stroke Belt to speed up stroke treatments, run trials, and bring better care to people at risk of stroke.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-11239003 on NIH RePORTER |
What this research studies
If you live in Alabama or Mississippi and are at risk for or have had a stroke, this network connects local hospitals so new treatments and care plans can be tested and offered sooner. The group brings together the University of Alabama at Birmingham, University of Mississippi Medical Center, University of South Alabama, and Children’s of Alabama and uses a neurology research unit and a clinical and translational science center to run studies. Staff get training and coordinator support to activate studies, collect patient data and biological samples, and manage trials across multiple sites. The goal is to make it easier for patients in the Stroke Belt to join trials and to bring proven advances into clinical care faster.
Who could benefit from this research
Good fit: People treated at the partner hospitals—adults and children who have had an acute stroke or are at high risk for stroke—are most likely to be eligible to participate.
Not a fit: People without stroke or stroke risk, or those not receiving care at the partner institutions, are less likely to be eligible or see direct benefit.
Why it matters
Potential benefit: If successful, the network could deliver new treatments and improved care practices more quickly to patients in the Stroke Belt, lowering stroke deaths and disability.
How similar studies have performed: National and regional stroke networks have supported successful clinical trials and faster enrollment, so this effort builds on an established and effective model.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Gropen, Toby — University of Alabama at Birmingham
- Study coordinator: Gropen, Toby
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.